Language：简体 / 繁體 / English

Luoxin Pharmaceutical，Source of Health

Luoxin Pharmaceutical，Source of Health


Luoxin Pharmaceutical，Source of Health

Luoxin Pharmaceutical，Source of Health


Luoxin Pharmaceutical，Source of Health

Luoxin Pharmaceutical，Source of Health


Development History

2017-2016
2015-2011
2010-2006
2005-2001
2000-1988

2017-2016

    2017

  • Jan. 18, 2017— —Jinan University held an internship agreement signing ceremony and opening ceremony for the practice base of Jinan University in our company.
  • Jan. 9, 2017— —The project “the establishment and application of key technology system of chemicals in crystal form” jointly accomplished by Institute of Materia Medica, Chinese Academy of Medical Sciences, Luoxin Pharmaceutical Group Co. Ltd. and other units won “the Second Prize of National Scientific and Technological Progress Award”.

    2016

  • Dec. 15, 2016— —Hengxin Pharmaceutical Co. Ltd. was certificated to be a high and new tech enterprise.
  • Dec. 2 ~ 4, 2016— —The company participated in the 76th national drug trade fair and held a grand press conference and customer appreciation meeting.
  • Dec. 1, 2016— —Luoxin Pharmaceutical Group Co. Ltd., Shandong won 2016 “Outstanding Brand Value Award” with the strong recommendation of Shenzhen Henghe Media and the appraisal of China Pharmaceutical Enterprise Management Association, National Health Industry Enterprise Management Association, China Medical Pharmaceutical Material Association and National Medical Pharmaceutical Elite Club.
  • Nov. 26, 2016— —The inaugural meeting of the 2nd meeting of the 4th council of Alumni Association of Shenyang Pharmaceutical University and the 5th Alumni Association Summit Forum and Shandong Alumni Association of Shenyang Pharmaceutical University was successfully held in the company.
  • Nov. 22, 2016— —The company continuously entered “top 100 enterprises in China pharmaceutical industry” and ranked No. 28 from 2015 to 2016; Luofeng entered 2016 “Brand in China” -- China-made medicine • brand list; Lanchuan ranked among “the 12th Five-Year scientific and technological achievement list in China pharmaceutical industry”.
  • Nov. 2016— —Luoxin Pharmaceutical Co. Ltd. won the title of “national technological innovation model enterprise”, which marked that Luoxin Pharmaceutical Co. Ltd. was recognized in technological innovation and research and development abilities by national authorities again and became another national innovative platform after the affirmation of “national-recognized enterprise technology center” in 2014.
  • Nov. 22, 2016— —The company continuously entered “top 100 enterprises in China pharmaceutical industry” and ranked No. 28 from 2015 to 2016; Luofeng entered 2016 “Brand in China” -- China-made medicine • brand list; Lanchuan ranked among “the 12th Five-Year scNov. 2016— —Luoxin Pharmaceutical Co. Ltd. won the honorary title of “national enterprise honoring contract and standing integrity”.ientific and technological achievement list in China pharmaceutical industry”.
  • Oct. 10, 2016— —Wang Shujian, the vice governor of provincial government of Shandong province, visited Luoxin and investigated and guided the work.
  • Oct. 2016— —A grand completion ceremony for management center building of Hengxin Pharmaceutical Co. Ltd. of Luoxin Group was held, marking Hengxin branch’s quality improvement in production and life conditions and the successful completion of Hengxin Phase I project.
  • Sept. 28, 2016— —A grand opening ceremony of Runxin Pharmaceutical Co. Ltd. of Luoxin Pharmaceutical Group was held. The full completion of the project created a modern pharmaceutical logistics distribution center with the highest degree of automation, the most complete variety of drugs, the widest delivery range and the largest area in northwest region of Shandong.
  • Sept. 2016— —Chinese drug 1.1 SCC-31 jointly researched and developed by the company, Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University got clinical approval and was expected to be developed into a conveniently prepared and highly active anti-tumor drug.
  • Sept. 2016— —Hengxin Pharmaceutical Co., Ltd. of Luoxin Pharmaceutical Group passed Japanese AFM site certification, which was an important step going abroad and developing international market. The company taking this certification as an opportunity would gradually achieve COS and FDA international certification, popularize products in the international high-end market and realize brand internationalization.
  • Sept. 19, 2016— —A grand foundation stone laying ceremony for modern pharmaceutical logistics center of Luoxin Pharmaceutical Group was held. The full completion of the project created a modern pharmaceutical logistics distribution center with the highest degree of automation, the most complete variety of drugs, the widest delivery range and the largest area in northwest region of Shandong.
  • Jul. 2016— —The 33th national pharmaceutical industry information annual meeting released “2015 top 100 enterprises in China pharmaceutical industry” and our company was rated as “the best industrial enterprise of China pharmaceutical research and development product line” again and continuously ranked No. 35 among “top 100 enterprises in China pharmaceutical industry”.
  • Jul. 2016— —The first Youth League branch of our company won the honorary title of “May 4th Red Flag Youth League branch of Shandong”.
  • Jul. 2016— —Cefazedone sodium passed Korean MFDS official audit.
  • Jun. 30, 2016— —The party committee of Luoxin Group won the honorary title of “Shandong advanced basic-level party organization”.
  • May 30, 2016— —Ministry of Industry and Information Technology released 2016 industrialization integrated with informatization management system implementation pilot enterprises and our company was included in one of the national industrialization integrated with informatization management system implementation pilot enterprises.
  • May 13, 2016— —Our company won the honorary titles of 2015 “top 100 enterprises in China pharmaceutical industry”, “gold purchaser of top 10 groups in China pharmaceutical industry” and “law-abiding and high-integrity enterprise”.
  • May 10, 2016— —The project “the construction of new preparation system and the expansion of clinical indications of proton pump inhibitors and scale industrialization” firstly completed by our company won the First Prize of Shandong Scientific and Technological Progress Award and the project “the construction of new preparation system and industrialization of pharmaceutical preparation cefazedone sodium based on key technology” firstly completed by Hengxin Pharmaceutical Co., Ltd. won the Second Prize of Shandong Scientific and Technological Progress Award.
  • Apr. 21, 2016— —Luoxin Pharmaceutical Group ranked among Shandong 2015 top 100 tax payment enterprises and became one of top three enterprises in Linyi and also one of top five pharmaceutical enterprises in Shandong.
  • Feb. 2016— —Luoxin Pharmaceutical Group, Yuxin and Hengxin Pharmaceutical Co., Ltd. successfully passed ISO14001 environment management system certification and became one of the few enterprises one-time passing certification in domestic pharmaceutical industry.

2015-2011

    2015

  • Dec. 23, 2015— —Luoxin Group’s the 13th Five-Year Plan and 2016 job objective arrangement meeting were held.
  • Dec. 18, 2015— —The company won the honorary titles of 2015 Shandong “innovative enterprise”, “excellent enterprise serving people” and “integrity model enterprise” in pharmaceutical industry.
  • Dec. 2, 2015— —The company participated in the 74th national drug trade fair and held a grand press conference and customer appreciation meeting.
  • Nov. 26, 2015— —Luoxin Pharmaceutical Co. Ltd. announced a joint research and development of anti-cancer drugs with Shanghai Institute of Materia Medica of Chinese Academy of Sciences and Fudan University.
  • Nov. 9, 2015— —The company ranked No. 10 among 2015 top 100 industrial enterprises of comprehensive strength in China chemical pharmaceutical industry; Jinxin (ambroxol hydrochloride for injection) was rated as 2015 excellent product brand used in various departments in China chemical pharmaceutical industry and ranked No. 1; Lanchuan (lansoprazole for injection) was rated as 2015 excellent product brand used in the digestive system in China chemical pharmaceutical industry and ranked No. 2; Kalunxi (cefazedone sodium for injection) was rated as 2015 excellent product brand used in anti-infection in China chemical pharmaceutical industry and ranked No. 19.
  • Oct. 22, 2015— —Luoxin Pharmaceutical Co. Ltd. announced to cooperate with CJ HealthCare in China about CJ-12420.
  • Aug. 31, 2015— —Zhang Wufeng, the vice governor of Shandong province, visited Luoxin and investigated and guided the work.
  • Aug. 28, 2015— —Wang Shujian, the vice governor of Shandong province, visited Luoxin and investigated and guided the work.
  • Jul. 12, 2015— —A grand national pharmaceutical industry information annual conference was held in Chengdu, which released “2014 top 100 enterprises in China pharmaceutical industry” and “2015 the best industrial enterprises of China pharmaceutical research and development product line”. The company ranked No. 37 among “2014 top 100 enterprises in China pharmaceutical industry” and No. 3 among “2015 the best industrial enterprises of China pharmaceutical research and development product line”.
  • Jul. 7, 2015— —A foundation stone laying ceremony for the project start-up of Renxin Pharmaceutical Co. Ltd. of Luoxin Pharmaceutical Group was held in Gaotang, Liaocheng.
  • Jun. 29, 2015— —The 10th top 100 enterprises in China pharmaceutical industry and 2015 national pharmacy week was held in Tengchong (Yunnan) and released “2014 top 100 enterprises in China pharmaceutical industry” and “top 10 China’s most innovative pharmaceutical enterprises”. The company has continuously ranked among “top 100 enterprises in China pharmaceutical industry” since 2006, ranking No. 25 in 2014, and was rated as “top 10 China’s most innovative pharmaceutical enterprises” , ranking No. 6 in 2014.
  • Jun. 18, 2015— —Luoxin Pharmaceutical Group Co. Ltd., Yuxin Pharmaceutical Co. Ltd. and Hengxin Pharmaceutical Co. Ltd., Shandong passed national intellectual property management system certification (abbreviated as “standard implementation” certification), intellectual property management system met the standard GB/T29490-2013 and was honored with Intellectual Property Management System Certificate, and it became the 7th certificated pharmaceutical enterprise in Shandong.
  • Mar. 22, 2015— —Fan Daiming, the vice president of Chinese Academy of Engineering, visited our company, guided the work and made an informal discussion.

    2014

  • Nov. 2014— —Mrs. Li Minghua, the general manager of the group company, was rated as 2013 - 2014 national “ideal lecture and contribution comparison to strive for the realization of Chinese dream” innovation model by national “ideal lecture and contribution comparison” leading group office.
  • Nov. 2014— —Lanchuan (lansoprazole for injection) was rated as “2014 excellent product brand used in digestive system in China chemical pharmaceutical industry” by China Pharmaceutical Industry Association, China Association of Pharmaceutical Commerce, China Nonprescription Medicines Association, China Pharmaceutical Enterprise Development Association and Reed Sinopharm Exhibitions Co. Ltd.
  • Nov. 2014— —The company was rated as “2014 top 100 comprehensive strength industrial enterprises in China chemical pharmaceutical industry” by China Pharmaceutical Industry Association, China Association of Pharmaceutical Commerce, China Nonprescription Medicines Association, China Pharmaceutical Enterprise Development Association and Reed Sinopharm Exhibitions Co. Ltd.
  • Oct. 1, 2014— —On the occasion of the 65 anniversary of the founding of the People's Republic of China, a grand “Luoxin Group’s Yuxin branch Phase II project completion and group management center building admission ceremony” was held in the square before group management center building.
  • Jul. 2014— —Li Minghua, the general manager of the group company, was appointed as a member of the editorial board of Chinese Journal of Pharmaceuticals.
  • Jun. 29, 2014— —The company ranked No. 33 among “2013 top 100 enterprises in China pharmaceutical industry”. The company continuously ranked among “top 100 enterprises in China pharmaceutical industry” for 9 years and was rated as “the best industrial enterprise of China pharmaceutical research and development product line” for 4 years.
  • Jun. 2014— —Luoxin Biotechnology (Shanghai) Co., Ltd. was set up.
  • May 17, 2014— —Our company as a love donation unit was invited to attend “care for and help the disabled to achieve the dream of beautiful Chinese” themed “sunshine share -- Shandong helping the disabled charity award gala” held by Shandong Disabled Persons’ Federation.
  • Apr. 2014— —The company was rated as “2013 top 100 most influential enterprises in China pharmaceutical industry” by National Federation of Industry & Commerce, Medical & Pharmaceutical Chamber.
  • Feb. 20, 2014— —Wang Suilian, the vice governor, visited our company and guided the work.
  • Jan. 27, 2014— —The company successfully passed national safety production standardization level 3 enterprise appraisal and acceptance.
  • Jan. 7, 2014— —The company ranked among 2013 “top 50 private enterprises” and “public welfare star of private enterprise”.

    2013

  • Dec. 30, 2013— —The company won the honorary title of “model unit supporting justice and courage”.
  • Dec. 20, 2013— —The company was recognized as 2013 Shandong civilized unit.
  • Nov. 14, 2013— —The company was included in 2013 the first batch of Shandong superior enterprise cultivation.
  • Nov. 12, 2013— —Luoxin Pharmaceutical Co., Ltd. won the honorary title of “2013 top 100 industrial enterprises of comprehensive strength in China chemical pharmaceutical industry”.
  • Nov. 2013— —The company was rated as “excellent enterprise brand in China chemical pharmaceutical industry” by China Chemical Pharmaceutical Association.
  • Nov. 2013— —The company was rated as “council member of China Association of Narcotic Drugs” by China Association of Narcotic Drugs.
  • Nov. 4, 2013— —Liu Baoqi, the chairman of the company, ranked among 2013 Chinese annual character list of medical economics.
  • Nov. 1, 2013— —The company was confirmed to be 2013 the first batch of Shandong reserve pilot enterprises with the production capacity of emergency supplies.
  • Sept. 14, 2013— —The declared “guacetisal and guacetisal for oral suspension” was included in National Torch Plan and “cefazedone sodium and cefazedone sodium for injection” was included in National Key New Products Program.
  • Aug. 23, 2013— —The company won 2013 Shandong Pharmaceutical Science and Technology Achievement Award.
  • Jul. 2013— —The company won “Golden Bridge Award” of China Technology Market Association issued by national science and technology award office.
  • Jul. 17, 2013— —The company was rated as “the best industrial enterprise of China pharmaceutical research and development product line” again and continuously ranked among “top 100 enterprises in China pharmaceutical industry”, No. 39 by main business income.
  • May 31, 2013— —A grand opening ceremony for the establishment of Luoxin Group military office was held.
  • May 27, 2013— —The company won the honorary titles of “national industrial brand cultivation pilot enterprise” and “Shandong innovation driven development advanced unit”.
  • May 2013— —The company won the honorary title of “2013 100 Linyi key enterprises”.
  • May 2013— —Song Liangwei was rated as “Shandong model worker” by provincial government of Shandong province.
  • Apr. 20, 2013— —The company was recognized as Shandong medical reserve enterprise and the produced 9 products such as cefazedone sodium, cefamandole nafate and cefminox sodium for injection were included in the reserve plan.
  • Apr. 20, 2013— —The company was recognized as Shandong medical reserve enterprise and the produced 9 products such as cefazedone sodium, cefamandole nafate and cefminox sodium for injection were included in the reserve plan.
  • Jan. 12, 2013— —All representatives of the 18th National People’s Congress elected Liu Baoqi, the secretary of the party committee and chairman of the group, as the representative of the 12th National People’s Congress.

    2012

  • Dec. 13, 2012— —“Shandong star enterprise of Chinese patent” was successfully upgraded to two stars.
  • Dec. 2, 2012— —Four projects including “research and development of itraconazole granules” successfully passed the appraisement of sci-tech achievements.
  • Nov. 14, 2012— —The declared “national & local engineering laboratory for preparative techniques of freeze-dried powder injection” was approved to be “2012 national & local engineering laboratory” by National Development and Reform Commission.
  • Sept. 13, 2012— —The company won the honorary title of “the 8th top 100 China enterprise education advanced units”.
  • Sept. 13, 2012— —Another project “aztreonam and aztreonam for injection” was successfully included in National Torch Plan after “cefpirome sulfate and cefpirome sulfate for injection” and “cefepime dihydrochloride and cefepime dihydrochloride for injection”.
  • Aug. 20, 2012— —Ma Hongjian, the vice director of National Center for Biotechnology Development, visited the company and investigated scientific and technological innovation.
  • Aug. 17, 2012— —The company continuously ranked among “top 100 enterprises in China pharmaceutical industry” and was rated as “the best industrial enterprise of China pharmaceutical research and development product line” again.
  • Jun. 6, 2012— —Feixian People’s Hospital, Linyi People’s Hospital and Luoxin Pharmaceutical Co., Ltd. established a joint venture of the Second People’s Hospital of Feixian and a grand signing ceremony was held at Feixian Lidu Hotel.
  • May 2012— —Mrs. Li Minghua, the general manager, was appointed as master supervisor of China Pharmaceutical University.
  • Mar. 10, 2012— —The company won the honorary title of “2010 Private Scientific and Technological Development Achievement Award” issued by China Private Science and Technology Association.

    2011

  • Dec. 29, 2011— —The company won the honorary title of “provincial school-enterprise cooperation advanced unit in talent training”.
  • Dec. 19, 2011— —Shandong enterprise academician workstation was set with the joint approval of Organization Department of the Provincial Committee, Department of Science & Technology, Department of Finance, Department of Human Resources and Social Security and Science and Technology Association of Shandong Province.
  • Dec. 12, 2011— —The company participated in the 66th national drug trade fair.
  • Dec. 3, 2011— —Liu Zhenfei was included into the first batch of professional foreign language talents and confirmed as a professional foreign language talent in Shandong.
  • Dec. 2, 2011— —“Six sigma management model centered modern enterprise management system” won Shandong Enterprise Management Innovation Achievement Award.
  • Nov. 13, 2011— —Two products were included in “National New Products Program” and 4 products were included in “National Torch Plan” with the appraisal of the Ministry of Science and Technology of P. R. C.
  • Nov. 3, 2011— —The company won the honorary title of the first batch of “Shandong standard innovative enterprises”.
  • Nov. 2011— —The company was rated as “2010 top 100 enterprises in dug circulation industry” by the Ministry of Industry and Information Technology of P. R. C.
  • Sept. 30, 2011— —Liu Baoqi, the chairman of the company, was the only one winning “2011 Linyi Mayor Quality Contribution Award”.
  • Sept. 24, 2011— —“2011 Shandong academic annual conference on the development of hospital pharmacy and pharmacy department” sponsored by Shandong Pharmaceutical Association was successfully held in our company.
  • Sept. 6, 2011— —The company was recognized as the first batch of Shandong pilot enterprises of innovative methods with the appraisal of Department of Science & Technology of Shandong Province.
  • Sept. 2, 2011— —Lansoprazole for injection won Shandong industry-university-research cooperation exhibition (industrial design) Innovation Award with the affirmation of Shandong industry-university-research cooperation combined with coordination leading group office.
  • Aug. 23, 2011— —Li Minghua, the general manager of the company, won the title of “Shandong excellent engineer” with the joint appraisal of Shandong Association of Science & Technology, Development and Reform Commission, Economic and Trade Commission, Department of Science & Technology and State-owned Assets Supervision and Administration Commission.
  • Aug. 17, 2011— —The company was rated as “2011 the best industrial enterprise of China pharmaceutical research and development product line” (the First Prize) and continuously ranked among “top 100 enterprises in China pharmaceutical industry”.
  • Aug. 13, 2011— —Li Minghua, the general manager of the company, won the First Prize of Invention Entrepreneurship Award with the joint assessment of Shandong Intellectual Property Office and Invention Association.
  • Jul. 30, 2011— —The company ranked among “2011 top 20 Chinese most competitive pharmaceutical listed enterprises” elected by China Pharmaceutical Enterprise Management Association.
  • Jul. 9, 2011— —The company continuously ranked among 2010 top 100 enterprises in China pharmaceutical industry.
  • May 26, 2011— —An argument conference on the construction of Shandong enterprise key laboratory project was successfully held in our company.
  • Apr. 2011— —The company won “2010 Green Enterprise Management Award” issued by China Environment News Council.
  • Apr. 26, 2011— —Liu Baoqi, the chairman of the company, was awarded National Labor Medal.
  • Apr. 21, 2011— —The company participated in the 65th national drug trade fair in Chengdu.
  • Apr. 2011— —The developed 10 projects of sodium pantothenate, water-soluble vitamin for injection and so on were included in 2011 the first batch of Shandong technological innovation project. A
  • Apr. 7, 2011— —“Shandong freeze-dried powder injection key laboratory” was approved to be set with the approval of Department of Science & Technology of Shandong Province.
  • Mar. 20, 2011— —A grand foundation stone laying ceremony for the construction of Hengxin pharmaceutical project was held.
  • Jan. 17, 2011— —Two technological upgrading projects were included in 2011 Shandong Enterprise Key Technological Transformation Project Oriented Plan with the approval of Shandong Economic and Information Commission.
  • Jan. 2011— —“Shandong freeze-dried powder injection engineering laboratory” was approved to be set by Shandong Development and Reform Commission.
  • Jan. 10, 2011— —“Research on freeze-dried powder injections” became one of Shandong newly set 17 posts “Mount Tai scholars -- distinguished pharmaceutical experts ” with the approval of provincial party committee and provincial government.

2010-2006

    2010

  • Dec. 2010— —National patent for the invention of “cefepime dihydrochloride powder injection and its preparation methods” won the First Prize of the 11th Shandong Patent Award.
  • Dec. 16, 2010— —The company was rated as “Shandong pharmaceutical enterprise culture construction model unit” by Shandong Economic and Information Commission, Department of Commerce, Pharmaceutical Profession Association and Pharmaceutical Enterprise Culture Research Association.
  • Dec. 11, 2010— —The company was recognized as “key high-tech enterprise of National Torch Plan” by the Ministry of Science and Technology based on national high-tech enterprise.
  • Dec. 9, 2010— —The company participated in the 64th national drug trade fair in Nanchang.
  • Dec. 8, 2010— —The company was rated as the most successful company in the annual meeting of elite club Medical Observer.
  • Dec. 8, 2010— —The project “cefozopran hydrochloride crude drug and injections” was included in 2010 Shandong Torch Plan by Department of Science & Technology of Shandong Province.
  • Dec. 2, 2010— —The company was rated as “Shandong star enterprise of Chinese patent” by Department of Science & Technology and Intellectual Property Office of Shandong Province.
  • Nov. 23, 2010— —A grand foundation stone laying ceremony for the construction of “Staff Dining and Entertainment Center” project was held.
  • Oct. 2010— —The company continuously ranked among 2009 top 100 national pharmaceutical industry enterprises.
  • Oct. 6, 2010— —The research projects of cefpirome sulfate raw material and its preparations won the First Prize of 2010 Shandong Pharmaceutical Science and Technology Award.
  • Sept. 29, 2010— —The company was approved to set a “post-doctoral scientific research station” by Ministry of Human Resources and Social Security and National Post-Doctor Regulatory Commission.
  • Sept. 20, 2010— —The company won the honorary title of “2010 Linyi Mayor Quality Award”.
  • Sept. 6, 2010— —The newly developed 7 projects - ceftizoxime sodium crude drug, powder injection, etc. were included in 2010 Shandong Technological Innovation Project.
  • Sept. 2010— —Li Minghua, the general manager, won “2010 Linyi Highest Science and Technology Award”.
  • Aug. 23, 2010— —The company was recognized as “the second batch of innovative pilot enterprises in Shandong” by Department of Science & Technology of Shandong Province, State-owned Assets Supervision & Administration Commission of Shandong Province and Federation of Trade Unions of Shandong Province.
  • Jul. 21, 2010— —The company was recognized as “national industrial model enterprise of comprehensive new drug research and development technology platform (Shandong)” by Department of Science & Technology of Shandong Province.
  • Jul. 17, 2010— —A grand foundation stone laying ceremony for “Home of Luoxin” construction project was held.
  • Jul. 8, 2010— —The company participated in the 45th national new and special drug trade fair in Beijing.
  • Jul. 2, 2010— —The company won the title of “provincial enterprise honoring contracts and standing reputation”.
  • Jun. 2010— —The commercial company (Luoxin Pharmaceutical Co., Ltd.) ranked among 2009 top 100 national pharmaceutical business enterprises.
  • Jun. 2010— —The commercial company ranked among 2009 top 100 national pharmaceutical business enterprises.
  • Jun. 2010— —The company continuously ranked among 2009 top 100 enterprises in China pharmaceutical industry.
  • May, 2010— —The company was rated as “2009 top 100 enterprises in China pharmaceutical industry” by SFDA Southern Medical Economics Research.
  • May, 2010— —The company won “2010 Green Enterprise Management Award” issued by China Environment News Council.
  • Apr. 24, 2010— —The company participated in the 63th national drug trade fair in Xiamen.
  • Apr. 19, 2010— —Sang Guowei, the vice chairman of the Standing Committee of the National People's Congress, chairman of the Central Committee of the Chinese peasants' and workers' Democratic Party, president of Chinese Pharmaceutical Association and academician of Chinese Academy of Engineering visited Luoxin Group and guided the work.
  • Mar. 2, 2010— —A grand foundation stone laying ceremony for the construction of new plant area of Yuxin branch was held.

    2009

  • Dec. 2009— —The company was approved to set “Shandong engineering and technological research center for freeze-dried powder injections”.
  • Dec. 28, 2009— —Liu Baoqi, the chairman, won the Second Prize of the 4th “Invention Entrepreneurship Award” by Shandong Intellectual Property Office and Shandong Invention Association.
  • Dec. 2009— —The company was rated as “meritorious enterprise in Shandong pharmaceutical industry in the 60th anniversary of P.R.C.” by Shandong Pharmaceutical Profession Association.
  • Dec. 2009— —The company won the honorary title of “advanced private enterprise” by People's Government of Shandong Province.
  • Nov. 27, 2009— —The company participated in the 62th national drug trade fair in Chengdu and held a press conference and customer appreciation meeting, which further enhanced brand promotion and market influence and consolidated the construction of market network.
  • Nov. 24, 2009— —The company was recognized as national high and new technology enterprise based on provincial high and new technology enterprise.
  • Oct. 28, 2009— —The company purchased Qidong Pharmaceutical Co., Ltd. (Qingdao) and established Luosheng Pharmaceutical Co., Ltd., Luoxin Group, Shandong.
  • Oct. 2009— —Luoxin pharmaceutical graduate employment base of Shenyang Pharmaceutical University was inaugurated and set.
  • Aug. 2009— —The company was rated as “AAA integrity company” by Chinese Academy of International Trade and Economic Co-operation.
  • Jul. 25, 2009— —The company was awarded “youth employment and entrepreneurship training base” by the Central Committee of the Communist Young League.
  • Jun. 27, 2009— —The company participated in the 44th national new and special drug trade fair in Tianjin, which further enhanced brand promotion and market influence and consolidated the construction of market network.
  • Jun. 25, 2009— —The company was approved to set “Shandong certified enterprise technology center”.
  • May 29, 2009— —The company purchased Shandong Dingli Pharmaceutical Co., Ltd., and established Mingxin Pharmaceutical Co., Ltd., Luoxin Group, Shandong.
  • Apr. 29, 2009— —Liu Baoqi, the chairman, was awarded “Making People Rich & Built-up Shandong Model”.
  • Apr. 24, 2009— —The company participated in the 61th national drug trade fair in Zhengzhou, which further enhanced brand promotion and market influence and consolidated the construction of market network.
  • Apr. 22, 2009— —The company continuously ranked among 2008 top 100 enterprises in China pharmaceutical industry.
  • Mar. 17, 2009— —The company was awarded “2009 Shandong 3.15 famous enterprise image and outstanding good (service) exposition excellent unit” by 2009 Shandong 3.15 famous enterprise image and outstanding good (service) exposition.
  • Feb. 13, 2009— —Luoxin Pharmaceutical Co., Ltd. was included in Forbes’ list top 200 Chinese potential enterprises, rapidly ranking No. 34 from No. 144.
  • Jan. 3, 2009— —The company was continuously rated as “top 10 Chinese pharmaceutical enterprises of the greatest growth capacity”.

    2008

  • Dec. 14, 2008— —The company participated in the 60th national drug trade fair in Chengdu new international convention and exhibition center of century city, which further enhanced brand promotion and market influence and consolidated the construction of market network.
  • Nov. 25, 2008— —Luoxin Pharmaceutical Co., Ltd., Shandong won the honorary title of “Shandong enterprise with outstanding contribution to the development of pharmaceutical industry”.
  • Oct. 23, 2008— —Postdoctoral mobile workstation, teaching and training base and practice base Luoxin Pharmaceutical Co., Ltd. of Shenyang Pharmaceutical University were inaugurated and established.
  • Oct. 7, 2008— —A grand opening ceremony of Luoxin Medical City Phase I project - drug logistics and drug wholesale supermarket was held.
  • Sept. 17, 2008— —Luoxin passed the certification of provincial company technology center.
  • Sept. 3, 2008— —The company participated in the 43th national new and special drug trade fair in Yantai.
  • Jul. 18, 2008— —Classes for 2008 freshmen from Luoxin Group teaching base of Shenyang Pharmaceutical University started and industry-university-research cooperation was strengthened, which further enhanced the company’s scientific research and development strength.
  • Jun. 16, 2008— —Phase III productivity expansion project was completed and put into use and passed GMP certification. The company’s productivity was further expanded, laying a solid basis for the realization of the goal of “the 11th Five-Year Plan”.
  • May 7, 2008— —The company successfully invested Qilu Medical Investment Management Co., Ltd., unveiling a new chapter combining capital operation with product market management.
  • Apr. 26, 2008— —The company ranked among 2007 top 100 enterprises in China pharmaceutical industry and was rated as “2007 top 10 pharmaceutical enterprises of the greatest growth capacity”.
  • Apr. 15, 2008— —The company participated in the 59th national drug trade fair in Xi’an.
  • Apr. 7, 2008— —Jiang Yikang, the secretary of the CPC Shandong Provincial Committee, visited the company and highly appreciate the company’s proprietary brand creation and continuously enhanced core competitiveness.
  • Feb. 27, 2008— —The company won the title of “2007 top 100 private economy” awarded by Linyi Municipal Party Committee of the Communist Party of China and Linyi People’s Government.
  • Jan. 29, 2008— —The company won the title of “2007 top 10 pharmaceutical enterprises of the greatest growth capacity” again.

    2007

  • Dec. 6, 2007— —The company participated in the 58th national drug trade fair in Kunming and held a grand press conference on new product launch, Phase III project construction, Luoxin Medical City construction and joint venture of Qilu Luoxin Pharmaceutical Co., Ltd., which indicated that the company has developed rapidly and soundly.
  • Nov. 16, 2007— —Luoxin Pharmaceutical Co., Ltd. drew much attention from numerous investors worldwide and its market value increased rapidly, reaching up to 4.05 billion yuan.
  • Aug. 2, 2007— —The company participated in the 42th national new and special drug trade fair in Xiamen, which further promoted Luoxin brand improvement.
  • Jun. 7, 2007— —Luoxin Medical City Phase I project began, which expanded drug logistics business and took full advantages of the integration of industry and commerce, and the company consistently stepped forward.
  • May 16, 2007— —A foundation-stone laying ceremony of Luoxin Pharmaceutical Co., Ltd. Phase III expansion project was held, marking the continuous expansion of company’s scale.
  • Apr. 19, 2007— —The company ranked among top 100 enterprises in China pharmaceutical industry and became one of top 100 enterprises in China pharmaceutical industry, which indicated that the company’s comprehensive strength was raised to a new level.
  • Apr. 16, 2007— —The company participated in the 57th national drug trade fair in Dalian.
  • Feb. 8, 2007— —The company won the title of “2006 top 50 private economy” awarded by Linyi Municipal Party Committee of the Communist Party of China and Linyi People’s Government.
  • Jan. 16, 2007— —The company won the title of “top 10 China pharmaceutical enterprises of the greatest growth capacity” and became one of the top 10 fastest growing pharmaceutical enterprises in the pharmaceutical industry.

    2006

  • Dec. 1, 2006— —The company participated in the 56th national drug trade fair in Shenzhen and held a press conference on new product launch, which attracted over 600 businessmen all over the country, marking the company has developed into a famous company and has higher position in industry.
  • Nov. 16, 2006— —Luoxin trademark won the title of “Shandong famous trademark”, which further enhanced the popularity of “Luoxin” products and market competitiveness, effectively strengthened the protection strength of company trademark and drove the rapid development of the company.
  • Oct. 27, 2006— —Luoxin Pharmaceutical Co., Ltd. Phase II expansion project was completed and put into use. The completion of Phase II expansion project and the inaugural ceremony of management center building was held, which rapidly promoted scientific research and development, talent accumulation, brand promotion, scale and modernization development of the company.
  • Jun. 21, 2006— —The company obtained the 200th production license of “tiopronin injection” (H20066258), marking a new beginning of scientific research and development of the company.
  • May 19, 2006— —Many mainstream media from Hong Kong visited Luoxin pharmaceutical factory, which significantly promoted the brand and popularity overseas.
  • Apr. 19, 2006— —The company participated in the 55th national new and special drug exhibition in Zhengzhou (Henan) and developed a more mature market network.
  • Feb. 20, 2006— —Luoxin Pharmaceutical Co., Ltd., Shandong won the title of “Linyi top 50 private enterprises” awarded by Linyi Municipal Party Committee of the Communist Party of China and Linyi People’s Government.
  • Feb. 18, 2006— —A grand “press conference on Luoxin Pharmaceutical Co., Ltd. at Hong Kong H-stock and customer appreciation meeting” was held at Linyi Taoranju Hotel, which promoted the progressive development of the company’s capital market and product management market.
  • Jan. 6, 2006— —The company won the title of “2005 top 50 private economy taxpayers” awarded by Linyi Municipal Party Committee of the Communist Party of China and Linyi People’s Government.

2005-2001

    2005

  • Dec. 9, 2005— —Luoxin Pharmaceutical Co., Ltd. successfully went public in Hong Kong H-stock and the development opened a new milestone, which laid a solid foundation for the take-off of the company in the future.
  • Dec. 1, 2005— —The company participated in the 54th national drug trade fair in Chongqing, which promoted the healthy development of product market.
  • Nov. 28, 2005— —The company held a press conference on Luoxin pharmaceutical share listing at Conrad Hotel, Hong Kong.
  • Oct. 28, 2005— —The company held a foundation-stone laying ceremony of technology building and the constructed technology building became the landmark of Luoxin, which further promoted the development of scientific research.
  • Aug. 25, 2005— —The company participated in the 40th national new and special drug trade fair in Nanjing and held a grand press conference on new product launch at Hilton Hotel.
  • Jun. 6, 2005— —The company won the title of “top 20 private economy taxpayers” awarded by Linyi Municipal Party Committee of the Communist Party of China and Linyi People’s Government.
  • May 26, 2005— —The company obtained the 100th production license: national first-class new drug “gatifloxacin capsules (H20050941)”, Luoxin’s abilities of innovation and research and development were raised to a new level.
  • Apr. 2, 2005— —The company participated in the 53th national drug trade fair in Xiamen, which further promoted product sales and overall construction of sales network.
  • Feb. 16, 2005— —Luoxin Phase II expansion project laying a foundation started and mainly included newly constructed workshops for raw materials, workshops for orally administrated cephalosporins, subpackaging workshops for powder injections, quality control center, technology building and auxiliary facilities.
  • Jan. 19, 2005— —A grand press conference on customer appreciation meeting and new product launch was held at Linyi News Building, which deepened the friendship with clients nationwide.

    2004

  • Sept. 4, 2004— —The company participated in the 39th national new and special drug trade fair in Qingdao and held a press conference on new product launch, which powerfully promoted the expansion of product market.
  • Jul. 26, 2004— —The company participated in 2004 the 4th national new and special drug, OTC and health care drug trade fair in Shanghai.
  • Jun. 17, 2004— —The company won the title of “2003 top 20 private economy taxpayers” awarded by Linyi Municipal Party Committee of the Communist Party of China and Linyi People’s Government.
  • May 25, 2004— —The company participated in the 52th China international spring fair on pharmaceutical raw materials, intermediates, packaging and equipment in Nanjing (Jiangsu) and launched information technology exchange of raw materials.
  • Mar. 13, 2004— —The company participated in the 38th national new and special drug trade fair (specially packaged) in Hefei (Anhui) and new products drew much attention from businessmen throughout the country and the company signed a batch of product orders with clients.
  • Feb. 28, 2004— —A press conference on the marketing of many new products and GSP certification was successfully held at Linyi Taoranju Hotel.
  • Feb. 28, 2004— —Luoxin Pharmaceutical Co., Ltd., Linyi passed GSP certification.

    2003

  • Nov. 16, 2003— —Luoxin Pharmaceutical Co., Ltd., Linyi was relocated to a new premise - the intersection of Guihua Road and Hudong 2nd Road, Luozhuang District.
  • Oct. 19, 2003— —The company participated in national drug trade fair in Chengdu, successfully held a press conference at Chengdu Yinhe Dynasty Hotel and signed buying and selling agreements with over 800 businessmen simultaneously.
  • Jun. 6, 2003— —The construction of new premise of Luoxin Pharmaceutical Co., Ltd., Linyi began.
  • May 26, 2003— —The company won the title of “2002 top 20 private economy taxpayers” awarded by Linyi Municipal Party Committee of the Communist Party of China and Linyi People’s Government.
  • Mar. 31, 2003— —The company was recognized as a “high and new technology enterprise” by Department of Science & Technology of Shandong Province.
  • Mar. 26,2003— —A press conference on the initial domestic marketing of national first-class new drug - gatifloxacin freeze-dried powder injection was held at Linyi Taoranju Hotel, which attracted businessmen throughout the country to sign many buying and selling agreements.
  • Mar. 13, 2003— —National first-class new drug - gatifloxacin freeze-dried powder injection developed by the company was marketed in domestic, which filled in the blanks of the production of powder injection and freeze-dried powder injection in Linyi and national first-class new drug.

    2002

  • Aug. 23, 2002— —Three workshops for powder injection subpackaging, freeze-dried powder injection and crude drugs passed GMP certification and was put into production, which expanded the productivity, increased dosage forms and accelerated the development of the company.
  • Jul. 2, 2002— —Yiluo pharmacy was relocated and opened after expansion and became a medical insurance fixed-point unit.

    2001

  • Dec. 22, 2001— —New workshops for solid preparations successfully passed GMP certification and became one of the first batch of the certificated workshops nationwide.
  • Dec. 10, 2001— —Luozhuang Pharmaceutical Company of Linyi increased the funding and expanded the stock and was renamed as Luoxin Pharmaceutical Co., Ltd., Linyi.
  • Nov. 30, 2001— —Luoxin pharmaceutical factory, Shandong was successfully restructured into Luoxin Pharmaceutical Co., Ltd., Shandong and became a joint-stock company conforming to modern enterprise management system, with clearly-established ownership and defined responsibilities, and also a multi-channel investment company jointly established by 11 promoters of Luoxin Pharmaceutical Co., Ltd. (Linyi), Shenyang Pharmaceutical University, Lijun Group LLC, Jiaozhou Pharmaceutical LLC of Qingdao Guofeng Group, Linyi People’s Hospital, Shandong Pingyi People’s Hospital and Linyi Pharmaceutical Group Head Office, etc.
  • Nov. 18, 2001— —A foundation stone laying ceremony for raw material workshops for freeze-dried powder injections and cephalosporin was held, marking the beginning of the scale development of multiple dosage forms.
  • Jun. 18, 2001— —The inaugural meeting of Luoxin Pharmaceutical Co., Ltd. and the first general meeting of shareholders was successfully held.
  • Apr. 30, 2001— —Luoxin pharmaceutical factory started to be reorganized and the signing ceremony of Luoxin Pharmaceutical Co., Ltd. promoters was held, which laid a foundation for share listing.

2000-1988

    2000

  • Aug. 16, 2000— —A foundation stone laying ceremony for new workshops for solid preparations was held and GMP management was implemented.

    1999

  • Sept. 1, 1999— —Luozhuang Pharmaceutical Company of Linyi called a congress of all workers and staffs and decided to reorganize the company into a stock cooperative company and the staffs holding shares became shareholders.

    1997

  • Oct. 10, 1997— —A press conference on the marketing of national new drug Jieli was held at high-tech industrial development zone building.
  • Aug. 11, 1997— —The company was approved to produce national new drug Jieli, laying a solid basis for follow-up product development.
  • Aug. 11, 1997— —LuoXin pharmaceutical factory, Shandong was restructured into a stock cooperative company and moved forward to modern pharmaceutical company.

    1996

  • May 18, 1996— —LuoXin pharmaceutical factory, Shandong put into production.

    1995

  • Dec. 8, 1995— —LuoXin pharmaceutical factory, Shandong completed industrial and commercial registration, disclosing a new page of the integration of industry and commerce.
  • Nov. 30, 1995— —LuoXin pharmaceutical factory, Shandong was approved to produce 13 varieties of the first batch of products.
  • Apr. 22, 1995— —Linyi Pharmaceutical Company in high-tech industrial development zone (Shandong) was renamed as Luozhuang Pharmaceutical Company, Linyi, Shandong and obtained two certificates and one business license.
  • Mar. 22, 1995— —The construction of LuoXin pharmaceutical factory, Shandong started, marking the beginning of the second industry.
  • Mar. 22, 1995— —Linyi Pharmaceutical Company in high-tech industrial development zone (Shandong) was succeed in the takeover of grain and oil processing factory of Linyi Food Bureau.

    1993

  • Jan. 15, 1993— —Luozhuang Pharmaceutical Business Department of Linyi was renamed as Linyi Pharmaceutical Company in high-tech industrial development zone (Shandong), which was a turning point of a major company from a small pharmacy.

    1991

  • Mar. 18, 1991— —Yiluo pharmacy was opened.

    1989

  • Dec. 5, 1989— —The first loan of 80 thousand yuan was obtained from bank, which was a precious fund for business operation.
  • Mar. 8, 1989— —The first business meeting held at Luozhuang economic commission guesthouse invited nearly 30 hospitals, including about 100 distinguished guests, which successfully reached a buying and selling agreement. Business meeting was held once every quarter in succession for 8 years.

    1988

  • Nov. 6, 1988— —Luozhuang Pharmaceutical Business Department of Linyi began trial opening and was officially opened one month later.
  • Aug. 8, 1988— —Luozhuang Pharmaceutical Business Department of Linyi started to be built and an enterprise was pioneered with painstaking efforts.
News
News
Charity Campaign
Charity Campaign